Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-06-08
DOI
10.1016/j.annonc.2022.05.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
- (2022) Vicky Makker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
- (2021) Joyce F. Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-risk Endometrial Cancer
- (2021) Elke E.M. Peters et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer
- (2021) Elke E.M. Peters et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
- (2020) Soyoun Rachel Kim et al. GYNECOLOGIC ONCOLOGY
- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
- (2020) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
- (2020) Richard S. Finn et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
- (2020) M.R. Mirza et al. ANNALS OF ONCOLOGY
- PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
- (2020) Anne Sophie V M van den Heerik et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
- (2020) David S. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
- (2020) Aurélien Marabelle et al. LANCET ONCOLOGY
- Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer
- (2020) Ana Oaknin et al. JAMA Oncology
- HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
- (2020) Lisa Vermij et al. Cancers
- Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study
- (2019) Rhonda S. Arthur et al. CANCER CAUSES & CONTROL
- A systematic literature review of trials of survivorship interventions for women with gynaecological cancer and their caregivers
- (2019) Vanessa L. Beesley et al. EUROPEAN JOURNAL OF CANCER CARE
- Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903
- (2019) Linda Mileshkin et al. GYNECOLOGIC ONCOLOGY
- Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer
- (2019) Ayumi Shikama et al. International Journal of Clinical Oncology
- Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer
- (2019) Marcus E. Randall et al. JOURNAL OF CLINICAL ONCOLOGY
- Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis
- (2019) Giorgio Bogani et al. GYNECOLOGIC ONCOLOGY
- Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
- (2019) Stephanie M de Boer et al. LANCET ONCOLOGY
- Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
- (2019) Daniela Matei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
- (2019) Karin Stålberg et al. ACTA ONCOLOGICA
- Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers
- (2019) Joyce F. Liu et al. GYNECOLOGIC ONCOLOGY
- Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer
- (2019) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Uterine Cancer: Adjuvant Therapy and Management of Metastatic Disease
- (2019) Carien L. Creutzberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Update on Genetic Testing in Gynecologic Cancer
- (2019) Susan M. Domchek et al. JOURNAL OF CLINICAL ONCOLOGY
- LBA12Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601)
- (2019) Y Antill et al. ANNALS OF ONCOLOGY
- Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial
- (2019) D. Lorusso et al. GYNECOLOGIC ONCOLOGY
- Incorporation of molecular characteristics into endometrial cancer management
- (2019) Lisa Vermij et al. HISTOPATHOLOGY
- p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
- (2019) Naveena Singh et al. JOURNAL OF PATHOLOGY
- Interpretation of somatic POLE mutations in endometrial carcinoma
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- Life after endometrial cancer: A systematic review of patient-reported outcomes
- (2018) Robert Shisler et al. GYNECOLOGIC ONCOLOGY
- A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
- (2018) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study
- (2018) Iñigo Espinosa et al. HUMAN PATHOLOGY
- Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
- (2018) Amanda N. Fader et al. JOURNAL OF CLINICAL ONCOLOGY
- The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
- (2018) Jessica McAlpine et al. JOURNAL OF PATHOLOGY
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
- (2018) Stephanie M de Boer et al. LANCET ONCOLOGY
- Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial
- (2018) Michael S. Gee et al. RADIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
- (2018) B. G. Wortman et al. BRITISH JOURNAL OF CANCER
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Endometrial Carcinoma Diagnosis
- (2018) Robert A. Soslow et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- The future for follow-up of gynaecological cancer in Europe. Summary of available data and overview of ongoing trials
- (2017) S.C. Leeson et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
- (2017) Josee-Lyne Ethier et al. GYNECOLOGIC ONCOLOGY
- Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer
- (2017) Monika Janda et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases
- (2017) Joyce E. Lodeweges et al. Journal of Thoracic Oncology
- A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
- (2017) Emma C Rossi et al. LANCET ONCOLOGY
- Practical guidance for mismatch repair-deficiency testing in endometrial cancer
- (2016) E. Stelloo et al. ANNALS OF ONCOLOGY
- Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial
- (2016) K Beaver et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature
- (2016) V. R. Bollineni et al. JOURNAL OF NUCLEAR MEDICINE
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
- (2016) Inge C Van Gool et al. MODERN PATHOLOGY
- Body Fatness and Cancer — Viewpoint of the IARC Working Group
- (2016) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
- (2015) I. C. van Gool et al. CLINICAL CANCER RESEARCH
- Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
- (2015) Tjalling Bosse et al. EUROPEAN JOURNAL OF CANCER
- Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer
- (2015) Scott McMeekin et al. GYNECOLOGIC ONCOLOGY
- Salvage Cytoreductive Surgery for Recurrent Endometrial Cancer
- (2015) Taner Turan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer
- (2015) E. J. Diver et al. ONCOLOGIST
- Targeting PI3 kinase in cancer
- (2015) Todd M. Bauer et al. PHARMACOLOGY & THERAPEUTICS
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
- (2014) T. Bosse et al. EUROPEAN JOURNAL OF CANCER
- Pelvic Exenteration for Recurrent Endometrial Adenocarcinoma
- (2014) Vito Chiantera et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry
- (2014) Evangelia Katsoulakis et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
- (2014) David N. Church et al. JNCI-Journal of the National Cancer Institute
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study
- (2013) Shoji Nagao et al. GYNECOLOGIC ONCOLOGY
- Omitting Adjuvant Radiotherapy in Endometrial Cancer Increases the Rate of Locoregional Recurrences but Has no Effect on Long-Term Survival
- (2013) Gitte Ørtoft et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA
- (2012) M Jefford et al. BRITISH JOURNAL OF CANCER
- Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: Systematic review and meta-analysis of the literature
- (2012) Sima Kadkhodayan et al. GYNECOLOGIC ONCOLOGY
- External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma
- (2012) Bengt Göran Sorbe et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study
- (2012) Joan L. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical cytoreduction in stage IV endometrioid endometrial carcinoma
- (2011) K.K. Shih et al. GYNECOLOGIC ONCOLOGY
- Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–Results from two randomised studies
- (2010) Thomas Hogberg et al. EUROPEAN JOURNAL OF CANCER
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- Systemic therapy for recurrent endometrial cancer: a review of North American trials
- (2009) Thanh H Dellinger et al. Expert Review of Anticancer Therapy
- Magnetic Resonance Imaging of Endometrial Carcinoma
- (2009) Silanath Peungjesada et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
- (2008) P. B. Panici et al. JNCI-Journal of the National Cancer Institute
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
- (2008) LANCET
- Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
- (2007) Nobuyuki Susumu et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search